Germline pathogenic variants for breast cancer also increase contralateral breast cancer risk Presented ByProf. Siddhartha Yadav, Mayo Clinic, MN, USA TrialCARRIERS ConferenceSABCS 2022 1 February, 2023 18:27
BRCA2 linked to inferior outcomes with CDK4/6 inhibitors plus endocrine therapy Presented ByDr Anton Safonov, Memorial Sloan-Kettering Cancer Center, NY, USA ConferenceSABCS 2021 31 January, 2022 18:08